MedPath
FDA Approval

Tobramycin and Dexamethasone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
May 26, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Dexamethasone(1 mg in 1 mL)
Tobramycin(3 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

NuCare Pharmaceuticals,Inc.

NuCare Pharmaceuticals,Inc.

010632300

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin and Dexamethasone

Product Details

NDC Product Code
68071-2418
Application Number
ANDA064134
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
May 26, 2021
SODIUM SULFATEInactive
Code: 0YPR65R21JClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16Class: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 7S5I7G3JQLClass: ACTIBQuantity: 1 mg in 1 mL
Code: VZ8RRZ51VKClass: ACTIBQuantity: 3 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
TYLOXAPOLInactive
Code: Y27PUL9H56Class: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
© Copyright 2025. All Rights Reserved by MedPath